AI Science Tracker
EN

Artificial Intelligence-Based Prognostic Model for Urologic Cancers: A SEER-Based Study.

Affiliation not stated in the reviewed material · 26 Jun 2022 · medicine

Discovery

Artificial Intelligence-Based Prognostic Model for Urologic Cancers: A SEER-Based Study.

Source check: Source checked. Not independent scientific confirmation.

Finding: A recurrent neural-network risk model estimated cancer-specific mortality across six named urologic cancer groups using SEER data and a held-out test set. Organization is unavailable in the deposited bibliographic metadata.

Technology: Recurrent neural network for cancer-specific mortality risk

Publication: Publication status unspecified in annotation · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Methods describe SEER cohort, recurrent model and test set; Results report risk stratification across urologic cancers.
Test and result
A recurrent neural-network risk model estimated cancer-specific mortality across six named urologic cancer groups using SEER data and a held-out test set.
Limitation / still unknown
The reviewed study does not establish validation or benefit beyond its reported evaluation.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC9264864/

The legacy label “Not reported” does not distinguish information absent from reviewed material from information not assessed. It is not a scientific finding of absence.

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.